Expand your menopause portfolio
Clinically tested, patent-protected products for perimenopausal and postmenopausal women. Available for distribution and licensing in international markets.
Menopause portfolio for pharmaceutical companies
Over
1
billion women
USD 24,35 Billion by 2030
A transition involving multiple needs
Vasomotor symptomps
Hot flashes, night sweats and sleep disruption.
Mood & cognitive changes
Irritability, mood fluctuations, concentration difficulties.
Urogenital changes
Vaginal dryness, discomfort and painful intercourse.
Bone health
Bone density loss and bone metabolism changes.
Vasomotor & metabolic health
Protage
Urogenital health
Ialos®
Santes®
Santes® Gel
Bone & healthy ageing
Synostea®
about lo.li pharma
25+ years of research.
- Patented technologies
- Clinical evidence
- International licensing experience
Medical Education & Training
Scientific training, periodic refreshers and field support for medical and commercial teams.
Clinical Research Partnership
Collaborative clinical research designed to strengthen product evidence and support long-term market differentiation.
Launch and commercial support
Launch planning, KOL engagement, educational events and scientific communication to maximize market success.
Marketing & Scientific Resources
Product presentations, visual assets, scientific publications and promotional materials continuously updated and ready for local adaptation.
Explore Partnership Opportunities
A digital space for market insights
- Access market insights
- Explore scientific and commercial resources
- Share posts to encourage discussion

PCOS Becomes PMOS: A New Name for Women’s Endocrine-Metabolic Health
Alpha-lactalbumin is gaining attention in nutraceutical research for its biological properties and its potential role in formulation design.